You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ravulizumab

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)

Active, not recruiting
  • Covid19
  • +2 more
  • Ravulizumab
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 31, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (OMS906 Study Drug - 3 mg/kg, OMS906 Study Drug - 5 mg/kg, Ravulizumab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • OMS906 Study Drug - 3 mg/kg
  • +2 more
  • Aachen, Germany
  • +4 more
Jul 25, 2023

Generalized Myasthenia Gravis, gMG Trial (Ravulizumab)

Not yet recruiting
  • Generalized Myasthenia Gravis
  • gMG
  • Ravulizumab
  • (no location specified)
Dec 1, 2022

Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)

Recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Ravulizumab
  • Barcelona, Spain
    Clinical Trial Site
Jul 6, 2022

Healthy Trial in London (Ravulizumab, rHuPH20)

Completed
  • Healthy
  • London, United Kingdom
    Clinical Trial Site
May 25, 2022

Ravulizumab in Italian Paroxysmal Nocturnal Hemoglobinuria

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Ravulizumab
  • Brescia, Italy
  • +5 more
Jul 13, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
    Regeneron Research Facility
Jan 28, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Ravulizumab
  • +2 more
  • Whittier, California
  • +8 more
Nov 29, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria
  • Ravulizumab
  • Atlanta, Georgia
  • +8 more
Aug 15, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930, Eculizumab, Ravulizumab)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Paris, France
  • +6 more
Dec 15, 2022

Paroxysmal Nocturnal Hemoglobinuria, PNH Trial in Worldwide (Ravulizumab)

Completed
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria
  • PNH
  • Ravulizumab
  • Toronto, Ontario, Canada
  • +15 more
Dec 7, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Leeds, London (Eculizumab, Ravulizumab)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Eculizumab
  • Ravulizumab
  • Leeds, United Kingdom
  • +1 more
Sep 21, 2021

Healthy Trial in London (ALXN1210 SC, ALXN1210 IV, Placebo)

Completed
  • Healthy
  • ALXN1210 SC
  • +2 more
  • London, United Kingdom
    Clinical Trial Site
Mar 11, 2022

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Dermatomyositis Trial in Worldwide (Ravulizumab, Placebo)

Recruiting
  • Dermatomyositis
  • Ravulizumab
  • Placebo
  • Orange, California
  • +35 more
Aug 16, 2022

Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Best Supportive Care)

Active, not recruiting
  • Thrombotic Microangiopathy
  • Ravulizumab
  • Best Supportive Care
  • Birmingham, Alabama
  • +57 more
Jan 31, 2023

Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Placebo, Best supportive care)

Recruiting
  • Thrombotic Microangiopathy
  • Ravulizumab
  • +2 more
  • Tampa, Florida
  • +90 more
Jan 26, 2023

Healthy Trial in Montréal (ALXN1210, Placebo)

Completed
  • Healthy
  • MontrĂ©al, Canada
    Clinical Trial Site
Mar 11, 2022

Healthy Trial in London (ALXN1210, Placebo)

Completed
  • Healthy
  • London, United Kingdom
    Clinical Trial Site
Mar 11, 2022

Healthy Trial in London (ALXN1210)

Completed
  • Healthy
  • London, United Kingdom
    Clinical Trial Site
Mar 11, 2022

Chronic Kidney Disease, CKD, Cardiac Disease Trial in Worldwide (Placebo, Ravulizumab)

Not yet recruiting
  • Chronic Kidney Disease
  • +3 more
  • Placebo
  • Ravulizumab
  • San Francisco, California
  • +96 more
Feb 27, 2023

Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Ravulizumab)

Active, not recruiting
  • Neuromyelitis Optica
  • Neuromyelitis Optica Spectrum Disorder
  • Ravulizumab
  • Birmingham, Alabama
  • +67 more
Feb 3, 2022

Amyotrophic Lateral Sclerosis, ALS Trial in Worldwide (Placebo, Ravulizumab)

Terminated
Has Results
  • Amyotrophic Lateral Sclerosis
  • ALS
  • Placebo
  • Ravulizumab
  • Phoenix, Arizona
  • +94 more
Dec 15, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Ravulizumab, Eculizumab)

Completed
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Ravulizumab
  • Eculizumab
  • Duarte, California
  • +48 more
Jul 14, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (LNP023, Eculizumab, Ravulizumab)

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Duarte, California
  • +39 more
Jan 13, 2023